Commercialization


  • Image attribution tooltip
    Spencer Platt via Getty Images
    Opinion

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

    By Taren Grom • Jan. 14, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice

    Welcome to the new PharmaVoice

    A similar mission, a new format, and our plans for PharmaVoice's next chapter.

    By Davide Savenije • Jan. 13, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Letter from the Editor

    Gratitude A simple thank you feels entirely inadequate to express our gratitude to you — our thought leaders, partners, and readers — for trusting us to be your forum for the exchange of ideas, perspectives, and insights over the past 20-plus years. Thank you to the more than 20,000 of you who ha...

    By Taren Grom • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Upfront

    Glen de Vries In MEMORIAM On Nov. 11, 2021, the world lost a healthcare visionary and trailblazer when Glen de Vries, 49, co-CEO of Medidata, died in a plane crash in New Jersey. Most recently, Glen fulfilled a lifelong dream in October 2021, as a member of the Blue Origin NS-18 crew, going into ...

    By PharmaVoice Team • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    HealthTech

    Headspace and Ginger Merged into Headspace Health Trend Watch: Advancing Digital Health and Therapeutics Support Mental Health Crisis Headspace, a global leader in mindfulness and meditation, and Ginger, a leader in on demand mental healthcare, have merged into Headspace Health, which aims to be ...

    By PharmaVoice Team • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Q&A

    Last Word: PharmaVOICE The Next Frontier

    With Industry Dive acquiring PharmaVOICE, Taren Grom, Editor of PharmaVOICE, sat down with Davide Savenije, Editor-in-Chief of Industry Dive, to discuss what’s coming in 2022, and what you, our community, can expect with the relaunch in January. PV: After 20-plus years as a print publica...

    By Davide Savenije • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    SHOWCASE: Technology Solutions: A Technology-Based Industry

    From clinical research to regulatory processes to manufacturing and beyond, technology is now well-entrenched in every part of the pharmaceutical industry Technology is part and parcel of the life sciences. It both shapes current and future innovations and, in the age of personalized medicine, is...

    By PharmaVoice Team • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    KOL Digital Listening: Going Beyond the Search for Digital Opinion Leaders

    Over the past three years the amount of scientific discussion online has accelerated. Digital platforms like social media, websites, blogs, news, and video are being used by the medical community to share new data, discuss treatments, and educate about diseases across all therapeutic areas. Medic...

    By Scott Thompson • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Reimagining the SpecialtyRx Patient Journey Through the Lens of a Digital Consumer

    Since the onset of COVID, the world has seen a radical shift by consumers to digital channels out of both safety and convenience. This shift has occurred not just for everyday goods and services like online grocery delivery and digital banking, but also with big-ticket decisions — such as 30% of ...

    By Scott Snyder • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Data and Technology: The Key to Patient-Centric Clinical Research

    A convergence of trends is transforming the trial experience and increasing efficiencies. Patient-centricity has become a driving force in clinical research. Patients expect trials to be built around their needs as a factor of participation, while regulators expect to see more diverse patient pop...

    By Susan Bacheller • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    A Strong Patient Support Partnership: Balancing Technology + Talent

    Improve Efficiency and Enhance Patient-Centricity Technology is growing at a fast clip in patient service hubs. Completing information online is the norm for tech-savvy patients, with automation providing speed and cost reduction. At the same time, patients require personal support to access, und...

    By Karl Raabe • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    The Rise of the Virtual Rep

    For more than three decades, detailing has been one of the cornerstones of the pharmaceutical industry’s communications with physicians. Thanks to recent advances in technology, what started out as face-to-face meetings between pharmaceutical sales representatives and physicians has evolved into ...

    By Ralph Greene • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Augmenting AI for Music Therapy Could Be Part of Your Next Marketing Gig!

    Music has always been a passion of mine. I’ve been playing the drums for years and it has always been there for me during the good times and very therapeutic in managing the stressful times in my life. Looking back to when I first began to immerse myself in learning how to play, I couldn’t have i...

    By Joe Tozzini • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Pandemic Tailwind Accelerating Adoption of AI-Powered Data Analytics Solutions

    Throughout history there have been seminal moments in time when humankind has been forced to rethink commonly accepted ways of doing things, as well as the beliefs that have held them in place. In many cases these pivots were brought about by milestone events that forced the reexamination of stan...

    By Sagar Anisingaraju • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Engaging Patients and Providers in A Digital World Utilizing Virtual Assistants and In-Workflow Services

    It’s evident within our healthcare system just how challenging it can be for patients to receive information and status updates regarding their care. Portals, apps, and websites all pose challenges for patients: remembering logins, potentially missing or incomplete data, and the inability to keep...

    By Ron Lacy • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    SHOWCASE: Supply Chain: Addressing Supply-Chain Vulnerabilities

    After COVID-19, pharma companies are eyeing different ways to ensure their supply chains remain resilient to future disruptions. When the world was hit by the COVID-19 pandemic, supply chains around the world faced almost instant disruption. The pandemic exposed vulnerabilities and highlighted th...

    By PharmaVoice Team • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    The Cost of Overlooking Ancillary Supplies in Protocol Development

    Recent upheaval in the global supply chain can no longer be seen through a crisis-control lens. It is a new reality forcing leaders, teams, and entire organizations to fundamentally change their approaches. It is arguable that the impacts are felt most acutely in pharma, where delays carry coloss...

    By Joanne Santomauro • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Opinion

    Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli

    The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...

    By Clark Wooten • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Artificial Intelligence

    Optellum and J&J Initiative Partner on Lung Health AI-driven Clinical Decision Platform Trend Watch: AI Continues to Accelerate R&D Efforts Across Diseases States Optellum, a lung-health AI company, has entered a strategic collaboration with the Lung Cancer Initiative at Johnson & Joh...

    By PharmaVoice Team • Oct. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    SHOWCASE: Artificial Intelligence: AI Here and Now

    Companies have increasingly turned to machine learning and AI to improve R&D, manage costs, and address stakeholder expectations. Artificial intelligence and machine learning are no longer futuristic innovations. Today, AI is widely used within the pharmaceutical industry, with the market exp...

    By PharmaVoice Team • Oct. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Artificial Intelligence, Buyer-Intent Data, and Account-Based Marketing: How Technology Has Changed the Way We Do B2B Marketing and Sales

    The new world of B2B marketing is now shaped by data-driven decision-making by way of artificial intelligence (AI) and buyer-intent data. These two technologies allow for better understanding of what your customers want and can help you discover hidden business opportunities in near “real time." ...

    By Jonathan Agoot • Oct. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    AI: Rewriting the Clinical Development Handbook

    The life-sciences industry is at a critical and unprecedented inflection point in terms of AI. Since the start of the global pandemic the use of AI by biopharma has gone from tactical to transformational. Traditionally employed during the research phase of R&D to identify drug candidates, syn...

    By Jonathan Burr • Oct. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    SHOWCASE: Patient Engagement: Digital Control: Putting Solutions Into the Hands of Patients

    Patient engagement solutions are key to clinician-patient interaction, improving compliance, enabling real-time reporting, and reducing visits to the doctor and hospital. Patients today want and expect to have greater control over their healthcare journey. They are accustomed to accessing informa...

    By PharmaVoice Team • Oct. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    From Mass Marketing to Precision Marketing: The Revolution Is Now

    The time is now — patients have firmly established themselves as savvy and engaged consumers. And they are becoming more empowered every day — with more access to research and information, online connections to other patients like themselves, and demanding more from a healthcare system that was a...

    By Heather Campbell • Oct. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    Real-World Implications of High-Deductible Health Plans

    High deductible health plans (HDHPs) were created 20 years ago to foster a more consumer-driven and affordable healthcare landscape. Have they lived up to that vision? While these plans are beneficial for certain populations, new research suggests they may also play a role in broadening the exist...

    By Bonnie MK Donato • Oct. 1, 2021